Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Adenoma hipofisário secretor de hormônio de crescimento
Total 0 results
Nothing found
Sponsors and Collaborators
Pancreatic Cancer UK
Van Boven, Robert W., M.D.
FutureGen Biopharmaceutical (Beijing) Co., Ltd
Biorobotic Institute Scuola Superiore sant'Anna Pisa
Liming Cheng
Hopeful Aging
Klinikum Bad Woerishofen
Only For Children Pharmaceuticals
Kuwait University
Hoersholm Hospital
The People's Hospital of Guangxi Zhang Autonomous Region
Egyptian Russian University
Sahar Salehi
Xiao-Ming Mao
Kerstyn C. Zalesin, M.D.
Jia Liu
Genuv Inc.
Friedrich Miescher Institute for Biomedical Research (FMI)
Royal Hobart Hospital Research Foundation (funding source)
Marcus Vinícius Guimarães de Lacerda
View Full List
Medical Conditions
Airway Obstruction
Role of Vitamin D in IVF for Better Outcome
EHMT1
Pulmonary Invasive Aspergillosis
Gait Variability; Elders; Fall; Re-education
Secondary Hypertension to Endocrine Disorders
Raynaud Secondary to Other Autoimmune Disease
Enlarged Uterus
Stage II Vulvar Cancer
Advanced Gastric Cancer With Serosal Invasion
High Perinatal Mortality
Using Imagery to Maintain Muscle Mass Gains in the Quadriceps
Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia
Autologous Haematopoietic Stem Cell Transplant
Urinary Tract Carcinoma
Smith-Lemli-Opitz Syndrome
Pancytopenia Due to Chemotherapy
Global Health
Caffeine Dosage
Stereotype-threat
View Full List
Drug Interventions
Atezolizumab
Ruxolitinib
Methotrexate
HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
Enzalutamide, Abiraterone
Oxycodone, fentanyl
Flibanserin 100 mg dose every evening
PF-00868554
Cetrorelix 78 mg + 78 mg
Epimedium Prenylflavonoids Extract
Bortezomib/dexamethasone
CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
Indoximod
Insulin
Polyethylene glycol 3350
Cytarabine ARA-C
SERETIDE Diskus
Mupirocin Calcium
Lamivudine
Topotecan
View Full List
CROs by country
Contract Research Organizations in Albania
Contract Research Organizations in Austria
Contract Research Organizations in Burundi
Contract Research Organizations in Costa Rica
Contract Research Organizations in El Salvador
Contract Research Organizations in France
Contract Research Organizations in Italy
Contract Research Organizations in Lebanon
Contract Research Organizations in Mauritius
Contract Research Organizations in Montenegro
Contract Research Organizations in Norway
Contract Research Organizations in Switzerland
Contract Research Organizations in Trinidad & Tobago
CRO list by country
CROs in Rwanda
ACROSS Global
All CROs in Rwanda
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe